DSFIR logo

DSM-Firmenich AG Stock Price

ENXTAM:DSFIR Community·€18.7b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 36 Fair Values set on narratives written by author

DSFIR Share Price Performance

€73.14
-43.26 (-37.16%)
49.9% undervalued intrinsic discount
€146.00
Fair Value
€73.14
-43.26 (-37.16%)
49.9% undervalued intrinsic discount
€146.00
Fair Value
Price €73.14
AnalystHighTarget €146.00
AnalystConsensusTarget €114.65
AnalystLowTarget €87.39

DSFIR Community Narratives

AnalystHighTarget·Updated
Fair Value €146 49.9% undervalued intrinsic discount

Sustainability And Precision Nutrition Will Fuel Global Market Expansion

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·Updated narrative
Fair Value €108.95 32.9% undervalued intrinsic discount

Health And Bio-Based Trends Will Drive Future Success

0users have liked this narrative
0users have commented on this narrative
18users have followed this narrative
AnalystLowTarget·Updated
Fair Value €87.39 16.3% undervalued intrinsic discount

Regulatory And Merger Challenges Will Constrain Benefits But Spark Growth

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent DSFIR News & Updates

DSM-Firmenich (AMS:DSFIR) Has A Pretty Healthy Balance Sheet

Sep 28
DSM-Firmenich (AMS:DSFIR) Has A Pretty Healthy Balance Sheet

The DSM-Firmenich AG (AMS:DSFIR) Half-Yearly Results Are Out And Analysts Have Published New Forecasts

Aug 05
The DSM-Firmenich AG (AMS:DSFIR) Half-Yearly Results Are Out And Analysts Have Published New Forecasts

DSM-Firmenich AG (AMS:DSFIR) Shares Could Be 40% Below Their Intrinsic Value Estimate

Aug 02
DSM-Firmenich AG (AMS:DSFIR) Shares Could Be 40% Below Their Intrinsic Value Estimate

Is It Too Late To Consider Buying DSM-Firmenich AG (AMS:DSFIR)?

Jul 11
Is It Too Late To Consider Buying DSM-Firmenich AG (AMS:DSFIR)?

Pinning Down DSM-Firmenich AG's (AMS:DSFIR) P/S Is Difficult Right Now

Jun 15
Pinning Down DSM-Firmenich AG's (AMS:DSFIR) P/S Is Difficult Right Now

Does DSM-Firmenich (AMS:DSFIR) Have A Healthy Balance Sheet?

Apr 25
Does DSM-Firmenich (AMS:DSFIR) Have A Healthy Balance Sheet?

DSM-Firmenich AG Key Details

€13.0b

Revenue

€8.5b

Cost of Revenue

€4.6b

Gross Profit

€3.8b

Other Expenses

€718.0m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Feb 12, 2026
Earnings per share (EPS)
2.81
Gross Margin
35.02%
Net Profit Margin
5.52%
Debt/Equity Ratio
25.2%

DSM-Firmenich AG Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet and fair value.

1 Risk
4 Rewards

About DSFIR

Founded
1902
Employees
28608
CEO
Dimitri de Vreeze
WebsiteView website
www.dsm-firmenich.com

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. The Animal Nutrition & Health segment offers animal proteins, vitamins, performance solutions, and data-driven precision services. The company was founded in 1902 and is based in Kaiseraugst, Switzerland.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Swiss Market Performance

  • 7 Days: 3.5%
  • 3 Months: 3.1%
  • 1 Year: 2.9%
  • Year to Date: 5.8%
Over the last 7 days, the market has risen 4.0%, driven by gains in every sector, especially the Healthcare sector. In the last 12 months, the market has been flat. Looking forward, earnings are forecast to grow by 11% annually. Market details ›